Skip to main content

Irritable Bowel Syndrome News

Related terms: IBS, Spastic colon

Wheat, Gluten May Be Safe to Consume for Many With IBS and Self-Perceived Sensitivity

FRIDAY, July 25, 2025 – Patients with irritable bowel syndrome (IBS) with self-perceived gluten sensitivity react similarly to wheat, gluten, and sham challenges, according to a study published...

Childhood GI Disorders May Be Predictive for Interstitial Cystitis

TUESDAY, July 22, 2025 – Childhood gastrointestinal (GI) disorders may be predictive for interstitial cystitis (IC), according to a study published online June 25 in Neurourology & Urodynamics....

For Some, Gluten Intolerance Is Psychological, Study Says

TUESDAY, July 22, 2025 — Gluten intolerance might be all in the minds of some people with irritable bowel syndrome (IBS), results from a small-scale experiment indicate. People with the common d...

IBS Rates Nearly Doubled During the Pandemic

MONDAY, July 1, 2025 — The COVID-19 pandemic took a toll on Americans’ guts, researchers report. Gut disorders like irritable bowel syndrome (IBS) increased significantly during the COVID-19 pan...

Mediterranean Diet Provides Some Relief for Nonconstipated Irritable Bowel Syndrome

TUESDAY, June 10, 2025 – Adherence to a Mediterranean diet (MD) provides symptom relief in adults with diarrhea-predominant irritable bowel syndrome (IBS-D) or mixed bowel pattern IBS (IBS-M)...

This Easier-To-Follow Diet Might Help IBS Patients, Study Says

MONDAY, June 9, 2025 — The Mediterranean diet might be a reasonable alternative for people with irritable bowel syndrome (IBS) who find it tough to stick with a strict prescription diet, a new s...

IgG-Guided Elimination Diet Beneficial for Irritable Bowel Syndrome

THURSDAY, Feb. 20, 2025 – Patients with irritable bowel syndrome (IBS) on an immunoglobulin (Ig)G-guided elimination diet are more likely to have a 30 percent or greater reduction in abdominal pain...

Blood Test Could Guide Better Diet For Irritable Bowel Syndrome

WEDNESDAY, Feb. 19, 2025 – A blood test can help people with irritable bowel syndrome cut out specific trigger foods most likely to worsen their condition, a new study suggests. About 60% of IBS...

High-Fiber Diets Linked to Gut Health & Fewer Harmful Bacteria

WEDNESDAY, Jan. 22, 2025 – Could eating more fiber be the key to a healthier gut? Research suggests the answer is yes. The findings, published recently in the journal Nature Microbiology, analyzed...

ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome

THURSDAY, Oct. 31, 2024 – Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented...

FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation

FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ – Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the...

FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65

LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ – US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug...

Synergy Pharmaceuticals Announces FDA Approval of Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

NEW YORK--(BUSINESS WIRE) January 25, 2018 – Synergy Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Trulance (plecanatide) 3 mg tablet for the...

FDA Medwatch Alert: Viberzi (eluxadoline): Drug Safety Communication - Increased Risk of Serious Pancreatitis In Patients Without A Gallbladder

ISSUE: FDA is warning that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. An FDA review...

FDA Medwatch Alert: Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results

ISSUE: Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) to the consumer level which include the tablet, sublingual, and orally...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Gastrointestinal Disorders

Related drug support groups

escitalopram, amitriptyline, venlafaxine, MiraLax, Linzess, nortriptyline, dicyclomine, Metamucil, Bentyl, view more... doxepin, Imodium, clomipramine, cholestyramine, Amitiza, Xifaxan, polyethylene glycol 3350